HPV-vaccination til immunsupprimerede kvinder

Translated title of the contribution: HPV vaccination for immunosuppressed women

Dina Overgaard Eriksen, Marianne Pape, Lone Kjeld Petersen, Carsten Schade Larsen, Bjarne Kuno Møller, Anne Hammer

Research output: Contribution to journalJournal articleResearchpeer-review


Immunocompromised women are at increased risk of having HPV detected and developing HPV-related diseases such as genital warts, anogenital dysplasia, and cancer. This review aims to summarize the current literature regarding the immunogenicity of the HPV vaccine in immunocompromised women and to discuss whether HPV vaccination may be able to reduce the risk of cervical dysplasia and cancer. HPV vaccination induces an immune response in these women; however, it is unknown whether vaccination is effective in reducing the risk of cervical dysplasia and cancer. Further research is needed.
Translated title of the contributionHPV vaccination for immunosuppressed women
Original languageDanish
Article numberV01230005
JournalUgeskrift for Læger
Issue number3
Publication statusPublished - 5. Feb 2024


Dive into the research topics of 'HPV vaccination for immunosuppressed women'. Together they form a unique fingerprint.

Cite this